Seroatlas · Human Serome Atlas

IDH3A

Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial

Also known as: IDH3A_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P50213
Gene
IDH3A
Ensembl
ENSG00000166411
Chromosome
15
Canonical length
366 aa
Protein class
Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
Subcellular location
Mitochondria

OverviewNCBI Gene

Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the alpha subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

366 residues, UniProt reviewed canonical sequence.

>P50213|IDH3A
     1  MAGPAWISKV SRLLGAFHNP KQVTRGFTGG VQTVTLIPGD GIGPEISAAV MKIFDAAKAP
    61  IQWEERNVTA IQGPGGKWMI PSEAKESMDK NKMGLKGPLK TPIAAGHPSM NLLLRKTFDL
   121  YANVRPCVSI EGYKTPYTDV NIVTIRENTE GEYSGIEHVI VDGVVQSIKL ITEGASKRIA
   181  EFAFEYARNN HRSNVTAVHK ANIMRMSDGL FLQKCREVAE SCKDIKFNEM YLDTVCLNMV
   241  QDPSQFDVLV MPNLYGDILS DLCAGLIGGL GVTPSGNIGA NGVAIFESVH GTAPDIAGKD
   301  MANPTALLLS AVMMLRHMGL FDHAARIEAA CFATIKDGKS LTKDLGGNAK CSDFTEEICR
   361  RVKDLD

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IDH3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
93 nTPM

Expression across tissuesHPA

Tissue

  • tongue: 93 nTPM
  • skeletal muscle: 75 nTPM
  • heart muscle: 59 nTPM
  • parathyroid gland: 51 nTPM
  • duodenum: 34 nTPM
  • small intestine: 34 nTPM

Single-cell type

  • pdcs: 206 nCPM
  • cardiomyocytes: 135 nCPM
  • syncytiotrophoblasts: 110 nCPM
  • cone photoreceptor cells: 99 nCPM
  • thymic myoid cells: 88 nCPM
  • sertoli cells: 87 nCPM

Immune cell

  • plasmacytoid DC: 144 nTPM
  • non-classical monocyte: 54 nTPM
  • intermediate monocyte: 53 nTPM
  • myeloid DC: 43 nTPM
  • naive B-cell: 32 nTPM
  • classical monocyte: 27 nTPM

Brain region

  • choroid plexus: 83 nTPM
  • cerebral cortex: 75 nTPM
  • cerebellum: 73 nTPM
  • pons: 73 nTPM
  • hippocampal formation: 71 nTPM
  • white matter: 70 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IDH3A.

Disease | AllUniProt

Conditions IDH3A is implicated in, by any mechanism.

Disease | GeneticClinVar

21 pathogenic / likely-pathogenic of 312 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.55
gnomAD pLI
0.16
gnomAD missense Z
2.59
DepMap mean gene effect
-0.47
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IDH3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IDH3A as an antibody target. Whether an autoantibody or antibody against IDH3A could matter depends on whether native IDH3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IDH3A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label IDH3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IDH3A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...